View Information Collection Request (ICR) Package

Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.

View ICR - OIRA Conclusion

OMB Control No: 1218-0180	ICR Reference No: 202411-1218-003
Status: Active	Previous ICR Reference No: 202105-1218-005
Agency/Subagency: DOL/OSHA	Agency Tracking No: 1218-0180 (2024)
Title: Bloodborne Pathogens Standard (29 CFR 1910.1030)
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 04/11/2025
	Date Received in OIRA: 03/07/2025
Terms of Clearance:

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	04/30/2028	36 Months From Approved	04/30/2025
Responses	43,856,212	0	26,840,817
Time Burden (Hours)	7,870,142	0	5,727,929
Cost Burden (Dollars)	116,568,859	0	52,427,598

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Adjustment in Estimate
Annual Number of Responses	43,856,212	26,840,817	17,015,395
Annual Time Burden (Hours)	7,870,142	5,727,929	2,142,213
Annual Cost Burden (Dollars)	116,568,859	52,427,598	64,141,261

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The agency is requesting an adjustment increase of 2,142,213 burden hours (from 5,727,929 to 7,870,142). This increase is a result of updated data showing an increase in the number of facilities (from 701,563 to 793,728) and employees (from 8,425,607 to 16,975,449) affected by the Standard. Also, the operation and maintenance cost increase of $64,141,261 from $52,427,598 to $116,568,859 due to an increase in the number of employees receiving vaccines and HIV testing and the medical costs for vaccines and HIV testing went up.

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Belinda Cannon 202 693-2083 Cannon.Belinda@dol.gov

Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.